| Date Filed | Type | Description |
| 04/05/2023 |
4
| Sandrock Alfred (President and CEO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 7,437 shares
@ $7.83, valued at
$58.2k
|
|
| 02/22/2023 |
4
| Sandrock Alfred (President and CEO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 120,000 shares
@ $0
Granted 240,000 options to buy
@ $7.43, valued at
$1.8M
|
|
| 03/23/2022 |
4
| Sandrock Alfred (President and CEO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $0
Granted 940,600 options to buy
@ $8.55, valued at
$8M
|
|
| 02/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Sandrock Alfred (EVP, Research & Development) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 3,728 shares
@ $0 |
|
| 11/06/2020 |
4
| Sandrock Alfred (EVP, Research & Development) has filed a Form 4 on BIOGEN INC.|
Txns:
| Sold 1,500 shares
@ $350, valued at
$525k
|
|
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2019 |
4
| Sandrock Alfred (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 10,000 options to buy
@ $79.79, valued at
$797.9k
|
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2018 |
4
| Sandrock Alfred (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 12,500 options to buy
@ $94.64, valued at
$1.2M
|
|
| 02/28/2018 |
4
| Sandrock Alfred (EVP, Chief Medical Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Sold 259 shares
@ $290.83, valued at
$75.3k
|
|
| 02/27/2018 |
4
| Sandrock Alfred (EVP, Chief Medical Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Sold 908 shares
@ $293.44, valued at
$266.4k
Paid exercise price by delivering 208 shares
@ $292.78, valued at
$60.9k
Exercised 467 restricted stock units
@ $0
Disposed of 595 restricted stock units
@ $0 |
|
| 02/26/2018 |
4
| Sandrock Alfred (EVP, Chief Medical Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 727 shares
@ $284.81, valued at
$207.1k
Exercised 1,635 restricted stock units
@ $0
Disposed of 843 restricted stock units
@ $0 |
|
| 02/21/2018 |
4
| Sandrock Alfred (EVP, Chief Medical Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Sold 743 shares
@ $292, valued at
$217k
|
|
| 02/20/2018 |
4
| Sandrock Alfred (EVP, Chief Medical Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Sold 1,294 shares
@ $298.85, valued at
$386.7k
|
|
| 02/20/2018 |
4
| Sandrock Alfred (EVP, Chief Medical Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 596 shares
@ $299.38, valued at
$178.4k
Exercised 1,339 restricted stock units
@ $0
Disposed of 787 restricted stock units
@ $0 |
|
| 02/14/2018 |
4
| Sandrock Alfred (EVP, Chief Medical Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 598 shares
@ $316.63, valued at
$189.3k
Paid exercise price by delivering 718 shares
@ $316.63, valued at
$227.3k
Granted 3,315 restricted stock units
@ $0
Granted 8,290 restricted stock units
@ $0
Exercised 2,012 restricted stock units
@ $0
Disposed of 1,398 restricted stock units
@ $0 |
|
| 06/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/24/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/23/2013 |
4
| Sandrock Alfred (Grp SVP, Chief Medical Officer) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Sold 15,030 shares
@ $250.108, valued at
$3.8M
Exercised 15,030 options to buy
@ $60.56, valued at
$910.2k
|
|
| 06/24/2013 |
3/A
| Sandrock Alfred (Grp SVP, Chief Medical Officer) has filed a Form 3/A on BIOGEN IDEC INC. |
| 06/10/2013 |
3
| Sandrock Alfred (Grp SVP, Chief Medical Officer) has filed a Form 3 on BIOGEN IDEC INC. |